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Background In 2013, an estimated 2.8 million newborns died 
and 2.7 million were stillborn. A much greater number suffer 
from long term impairment associated with preterm birth, in-
trauterine growth restriction, congenital anomalies, and peri-
natal or infectious causes. With the approaching deadline for 
the achievement of the Millennium Development Goals (MDGs) 
in 2015, there was a need to set the new research priorities on 
newborns and stillbirth with a focus not only on survival but 
also on health, growth and development. We therefore carried 
out a systematic exercise to set newborn health research pri-
orities for 2013–2025.
Methods We used adapted Child Health and Nutrition Re-
search Initiative (CHNRI) methods for this prioritization exer-
cise. We identified and approached the 200 most productive 
researchers and 400 program experts, and 132 of them submit-
ted research questions online. These were collated into a set of 
205 research questions, sent for scoring to the 600 identified 
experts, and were assessed and scored by 91 experts.
Results Nine out of top ten identified priorities were in the do-
main of research on improving delivery of known interven-
tions, with simplified neonatal resuscitation program and clin-
ical algorithms and improved skills of community health 
workers leading the list. The top 10 priorities in the domain of 
development were led by ideas on improved Kangaroo Mother 
Care at community level, how to improve the accuracy of di-
agnosis by community health workers, and perinatal audits. 
The 10 leading priorities for discovery research focused on sta-
ble surfactant with novel modes of administration for preterm 
babies, ability to diagnose fetal distress and novel tocolytic 
agents to delay or stop preterm labour.
Conclusion These findings will assist both donors and re-
searchers in supporting and conducting research to close the 
knowledge gaps for reducing neonatal mortality, morbidity 
and long term impairment. WHO, SNL and other partners 
will work to generate interest among key national stakehold-
ers, governments, NGOs, and research institutes in these pri-
orities, while encouraging research funders to support them. 
We will track research funding, relevant requests for propos-
als and trial registers to monitor if the priorities identified by 
this exercise are being addressed
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About 2.9 million newborns died in 2011, accounting for 
44% of the world’s under-5 child deaths [1]. The propor-
tion of neonatal mortality continues to increase because the 
neonatal mortality rate is declining at a slower rate than the 
mortality rates for older children [1]. Moreover, 2.7 million 
stillbirths occur each year, at least 40% of which occur dur-
ing labour [2]. The leading killers of newborns are preterm 
birth complications, intrapartum–related events and neo-
natal infections such as pneumonia, sepsis or meningitis 
[3]. A high proportion of stillbirths, neonatal and also ma-
ternal deaths happen at birth and during the first days after 
birth – a total of over 3 million deaths [4]. This is also a 
critical time window to address acute morbidity and long–
term impairment associated with preterm birth, intrauter-
ine growth restriction (IUGR), congenital abnormalities, 
and perinatal or infectious insults [5,6].
With the approaching deadline for the achievement of the 
Millennium Development Goals (MDGs) in 2015, and the 
creation of new framework for development goals [7], there 
is an increasing need to guide the limited research capacity 
and funding to obtain the maximum impact on maternal 
and child health. Hence the World Health Organization 
(WHO) has initiated a set of global research priority–set-
ting exercises in 2007–2008 for improving health of moth-
ers, newborns, children and adolescents [8–12]. The five–
year evaluation of that exercise from the perspective of 
donors, policy–makers and researchers is currently under 
way and it is showing an increased focus on identified re-
search priorities from all three groups of stakeholders – in 
terms of investments by the donors [13,14], initiatives 
launched by policy–makers [15–19] and publication out-
put from researchers [2,20–23], respectively. As part of this 
initiative, the Department of Maternal, Newborn, Child 
and Adolescent Health undertook this exercise for setting 
research priorities in newborn health and stillbirth, in col-
laboration with Saving Newborn Lives (SNL), a program 
of Save The Children. The time frame for the expected im-
pact of the research extends to 2025 to allow for medium 
term and long–term research investments to also be con-
sidered. Alongside the persisting urgency of reducing mor-
tality and the findings from previous research priority ex-
ercises the group believed that the research should also 
address morbidity, development, and long–term sequelae 
of preterm birth, small for gestational age as well as other 
hypoxic or infectious insults in the neonatal period (Box 
1). In the exercise, we focused on intrapartum stillbirth as 
a high proportion of stillbirths occurs during the labour. 
METHODS
A working group that managed the agenda–setting process 
consisted of staff responsible for newborn health in WHO 
and Saving Newborn Lives. The group defined the scope 
of the priority setting exercise (Box 1). Methodology de-
veloped by the Child Health and Nutrition Research Initia-
tive (CHNRI) was adapted and used for this priority setting 
exercise, to enable systematic listing and transparent scor-
ing of many competing research questions [24–26]. This 
methodology had been used in the previous priority setting 
exercises by the WHO on five major causes of child deaths: 
pneumonia, diarrhea, preterm birth and low birth weight, 
neonatal infections, and birth asphyxia [8–12]. The previ-
ous exercise coordinated by the WHO was sharply focused 
on short–term gains, ie, within the MDG4 target of the year 
2015. In addition, the CHNRI methodology has been used 
by many other subject groups and multiple organizations 
[27–33]. Box 2 shows the steps we followed during this 
priority setting process.
A large group of researchers and program experts were 
identified and asked to submit three ideas for improving 
newborn health outcomes by 2025 (Box 2). Two hundred 
of the most productive researchers, representing a broad 
range of technical expertise and regional diversity, identi-
fied through Web of Science® ranking tools, were invited 
by email to propose research questions on newborn health 
and birth outcomes. A further 400 program experts in new-
born health programmes were also invited to propose re-
search questions.
The proposed research questions and scoring criteria were 
refined by a small group of 14 experts who were invited by 
the WHO to participate in a two–day workshop. Each 
question was assigned to a domain and a technical area. 
The first of the three domains was “discovery”, which in-
cluded research aimed at finding new solutions such as 
new medicines, vaccines or other preventive interventions, 
or new diagnostics. The second domain was “develop-
ment”, which included research questions aimed at im-
proving existing interventions, reducing their costs or mak-
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Box 1 The purpose and remit of this research priority setting 
exercise
Population of interest:
Newborns and stillbirths, survival and health, preterm birth, 
growth and impairment–free development
Time frame:
2013–2025, reaching beyond the timeframe of the Millen-
nium Development Goals
Research domains:
DISCOVERY (new interventions)
DEVELOPMENT (improved interventions)
DELIVERY (implementation of existing interventions)
(note: not including description eg, epidemiology)
Audience (stakeholders):
Governments, researchers in low and middle–income coun-
tries, international donors
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Box 2. Adapted Child Health and Nutrition Research Initiative's 
(CHNRI) methodology applied to set newborn research priorities
1. Selection of individuals to submit ideas and to score ques-
tions:
Individuals representing a wide range of technical expertise 
in the area of newborn health and birth outcomes were se-
lected by including
•  Top 100 most productive researchers in the previous 5 
years (2008–2012), according to the Web of Science®, in 
any research that involved neonates anywhere in the 
world, including (but not limited to) fundamental re-
search, obstetrics and gynaecology, social science, and oth-
er fields;
•  Top 50 most productive researchers in the previous 5 years 
(see above) in research specifically involving neonates in 
low and middle income countries (LMICs);
•  Top 50 most productive researchers in the previous 5 years 
(see above) in any research involving stillbirths;
•  400 program experts in newborn health, who were con-
tacted through the Healthy Newborn Network Database, 
representing mainly national–level health programme 
managers in LMICs.
2. Identification of questions to be scored:
All the identified individuals were approached and asked to 
submit their three most promising ideas for improving new-
born health outcomes by 2025. An expert group meeting was 
convened to review the 396 questions received from 132 ex-
perts. After removing or merging seemingly duplicate ideas, 
the submissions were consolidated into a set of 205 research 
questions and clarity of the questions was improved.
3. Scoring of research questions:
A set of 5 criteria to assess the proposed 205 research ques-
tions was agreed on.
The scoring criteria were based on CHNRI methodology 
[8–12]
i. Likelihood of answering the question in an ethical way
ii. Likelihood of efficacy
iii. Likelihood of deliverability and acceptability
iv. Likelihood for an important disease burden reduction
v. Predicted effect on equity
During the preliminary meeting, 14 experts invited from the 
larger pool of responders completed their scoring to test the 
methodology. The remaining experts were asked indepen-
dently to answer a set of questions via an online survey on 
all the chosen criteria for all listed research options. Scores 
from a total of 91 experts were received.
4.  Computation of scores for competing research options 
and ranking:
The intermediate scores were computed for each of the five 
criteria and they could potentially range between 0–100%. 
Those scores indicate the “collective optimism” of the group 
of scorers that a given research question would fulfil each 
given criterion. The overall research priority score for each 
research question was then computed as the mean of the in-
termediate scores. The average expert agreement scores were 
also calculated (Online Supplementary Document).
ing them simpler to deliver. The third domain was 
“delivery”, which included research questions that would 
help deliver existing interventions to more mothers and 
newborns with high quality. The five separate technical ar-
eas included: (i) preterm birth; (ii) intrapartum–related 
events including intrapartum stillbirths; (iii) newborn in-
fections; (iv) congenital malformations and other specific 
conditions; and (v) integrated care including the care for 
mothers and neonates;
The final list of research questions and scoring criteria were 
sent to the original group of 600 experts with an invitation 
to score them. Each research question was assessed by the 
expert and received a score of 1.0, 0.5 or 0 for five preset 
criteria, with the option of not assigning any score in case 
the expert did not feel confident to decide on that criterion. 
Scoring took place over eight weeks and was conducted and 
returned to the coordinators at the WHO by 91 experts.
Intermediate scores for each research question against the 5 
criteria were computed as the sum of the scores for that par-
ticular criterion divided by the total number of scorers. This 
resulted in a number between 0–100% that captured the “col-
lective optimism” of the group of 91 scorers that a given re-
search question would fulfill each given criterion. The overall 
research priority score (RPS) for each research question was 
then computed as the mean of the intermediate scores calcu-
lated for each of the five criteria: RPS = [(Criterion 1 score %) 
+(Criterion 2 score %)+(Criterion 3 score %)+(Criterion 4 
score %)+(Criterion 5 score %)]/5. The confidence interval 
was calculated using the bootstrapping methods in STATA 
version 11.2.
RESULTS
In total, 132 of the 600 invited experts proposed a total of 
396 research questions, which were then checked for simi-
larity and consolidated in a final list of 205 questions to be 
scored. The characteristics of respondents are summarized 
in Figure 1. The 205 research questions were then scored 
by 91 experts. About 40% of the scorers were based in low 
and middle income countries (LMICs) in Africa, Asia, and 
South America. About two–thirds (65%) worked in academ-
ic or research institutions and the remainder was divided 
between program managers (16%), clinicians (7%), donor 
representatives (7%) and policy makers (5%) (Figure 1).
The overall research priority scores given to the 205 pro-
posed questions ranged from 90% (high) to 47% (low; full 
list of scored questions is presented in the Online Supple-
mentary Document). The level of agreement between the 
91 experts ranged from 77% (high) to 34% (low), suggest-
ing that on average, for each research question of interest, 
between three–quarters and one–third of the scorers were 
in agreement in their responses to each criterion.
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born infections, two on preventing intrauterine growth re-
striction and one each on intrapartum–related events and 
antepartum stillbirths.
There was a remarkable similarity in the scoring pattern 
between experts from a research background and those 
from a program background for the top 10 ranked priori-
ties (Table 4). The programme experts had a tendency to 
assign somewhat higher overall scores to “delivery” ques-
tions, which was mediated through their higher scoring of 
maximum potential impact and equity criteria. Among “de-
velopment” questions, the scorers with a background in 
research gave higher scores for efficacy and deliverability, 
while programme experts gave higher scores for impact 
and equity criteria. Surprisingly, the scoring pattern of both 
groups of experts for “discovery” questions was very simi-
lar, both for overall score and for each of the 5 criteria.
DISCUSSION
In this paper, we present global research priorities that have 
the potential to impact mortality, morbidity, child develop-
ment, and long–term health outcomes among neonates in 
the period between 2013–2025. Despite the broad focus 
on these outcomes and a 12–year timeline, “delivery” ques-
tions received highest scores, followed by “development” 
and “discovery” questions, as was the case in previous ex-
ercises with shorter time lines focusing only on reducing 
mortality [8–12].
The overall scores for the highest priority questions ranged 
from 79% to 90% (Table 1). Agreement scores indicated that 
more than two thirds of the experts had a common view to-
wards the list of research priorities. Nine of the ten top pri-
orities were in the domain of “delivery”, with simplified neo-
natal resuscitation programs and clinical algorithms and 
improved skills of community health workers leading the 
list. Among the 11 priorities shown in this table, three ad-
dressed preterm birth, four addressed intrapartum–related 
events and four addressed newborn infections.
In the domain of “development”, the top 10 priorities (Ta-
ble 2) were ranked between 8th and 50th on the list of all 
research questions (displayed in full in Online Supple-
mentary Document). They were led by ideas on improved 
Kangaroo Mother Care, improve accuracy of diagnosis by 
community health workers, and perinatal audits. Two pri-
orities among the leading ten in this domain were identi-
fied in each of the areas of preterm birth, intrapartum re-
lated events and newborn infections, while the remaining 
4 priorities related to integrated care.
The 10 leading priorities for discovery research (Table 3) 
ranked between 55th and 129th on the list of all research 
questions (see Online Supplementary Document) and 
they focused on stable surfactant with novel modes of ad-
ministration, ability to diagnose fetal distress and novel to-
colytic agents. Agreement scores for the ten leading ques-
tions ranged from 42% to 49%. Three priorities were 
identified in each of the areas of preterm birth and new-
Figure 1. Background characteristics of 132 experts who provided questions and 91 experts who scored the questions.
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Table 1. Top ten research priorities for improving newborn health and birth outcomes by 2025 as ranked by 91 experts
Rank ReseaRch questions Domain total scoRe 
(confiDence 
inteRval)
agReement 
between 
scoReRs
answeRable? efficacy? DeliveRability? impact? equity?
1 Can simplified neonatal resuscitation program deliv-
ered by trained health workers reduce neonatal 
deaths due to perinatal asphyxia?
Delivery 90 (85–91) 77 96 91 94 77 92
2 How can the health worker's skills in preventing and 
managing asphyxia be scaled up?
Delivery 88 (83–89) 74 96 91 89 75 86
3 Can simple clinical algorithms used by CHW iden-
tify and refer neonates with signs of infection and 
consequently reduce newborn mortality?
Delivery 86 (83–89) 72 92 92 92 66 88
4 How can exclusive breastfeeding in low–resource 
contexts be promoted to reduce neonatal infections 
and mortality?
Delivery 85 (79–89) 72 94 89 86 69 86
5 Can the training of CHWs in basic newborn resusci-
tation reduce morbidity and mortality due to perina-
tal asphyxia?
Delivery 83 (78–86) 67 94 84 84 64 88
6 How can the administration of injectable antibiotics 
at home and first level facilities to newborn with 
signs of sepsis be scaled up to reduce neonatal mor-
tality?
Delivery 82 (78–86) 64 89 88 88 59 84
7 Can community–based initiation of Kangaroo Moth-
er Care reduce neonatal mortality of clinically stable 
preterm and low birth weight babies?
Development 80 (74–84) 66 86 87 81 69 77
8 How can facility based initiation of Kangaroo Mother 
Care or continuous skin–to–skin contact be scaled up?
Delivery 80 (71–84) 62 90 82 84 62 81
9 How can chlorhexidine application to the cord be 
scaled up in facility births and in low NMR setting to 
reduce neonatal infections and neonatal mortality?
Delivery 80 (70–83) 67 91 85 89 52 81
10 How can quality of care during labour and birth be 
improved to reduce intrapartum stillbirths, neonatal 
mortality and disability?
Delivery 79 (71–82) 65 83 84 82 72 75
11* Can community based “extra care” for preterm/LBW 
babies delivered by CHWs reduce neonatal morbid-
ity and mortality in settings with poor accessibility 
to facility care?
Delivery 79 (70–82) 63 87 87 81 62 81
*The overall and criterion specific scores ranged from 0% to 100%.The 11th question added to complete the list of top 10 priorities in the domain of 
“delivery”. The question originally ranked 5th was omitted from this table because it was a variant of question that already received a higher overall score.
Table 2. Top ten development research priorities for improving newborn health and birth outcomes by 2025 as ranked by 91 experts
Rank ReseaRch questions total scoRe
(confiDence inteRval)
agReement 
between scoReRs
8* Can community–based initiation of Kangaroo Mother Care reduce neonatal mortality of clinically stable pre-
term and low birth weight babies?
82 (78–86) 64
26 How can the accuracy of community health workers in detecting key most important high risk conditions or 
danger signs in pregnant women be improved?
77 (70–80) 61
35 Can perinatal audits improve quality of care in health facilities and improve fetal and neonatal outcomes? 74 (67–79) 58
37 Can intrapartum monitoring to enhance timely referral improve fetal and neonatal outcomes? 74 (67–79) 57
38 Can training community health workers to recognize and treat neonatal sepsis at home with oral antibiotics 
when referral is not possible reduce neonatal mortality?
74 (62–78) 57
40 Can oral amoxicillin at home for treatment of neonatal pneumonia reduce neonatal mortality? 73 (64–78) 58
43 Can models for strengthening capacity of health Professionals in caring for neonates in peripheral hospitals 
improve neonatal outcomes?
73 (63–77) 54
44 Can intervention package for CHWs to prevent and manage perinatal asphyxia be delivered by community 
health workers?
72 (64–77) 55
47 Can low–cost devices for facility care of newborns be developed and tested for the effectiveness at various 
levels of the health system (eg, CPAP devices, syringe drivers, IV giving sets, phototherapy units, oxygen con-
centrators, oxygen saturation monitors incubators, ventilators, therapeutic hypothermia technology) ?
72 (65–76) 53
50 Can surfactant reduce preterm morbidity and mortality in low and middle income countries? 72 (65–78) 56
*Also in the overall top 10 priorities.
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The major emerging themes in the domain of “delivery” 
included simplifying intervention delivery to implementa-
tion at lower levels of the health system, evaluating delivery 
of interventions by community health workers, developing 
strategies to improve quality of care during labour and 
childbirth, and addressing barriers in the scaling up of high 
impact interventions. It is interesting to note that 5 of the 
questions were related to neonatal resuscitation. This could 
be related to neonatal resuscitation being the most dramat-
ic intervention in newborn care. The major themes in the 
domain of “development” were adapting known interven-
tions to make them deliverable at the community level, 
adapting effective interventions to increase deliverability in 
health facilities in low and middle income countries, and 
approaches such as perinatal audits to improve quality of 
care to mothers and newborns. The themes in the domain 
of “discovery” included new, more effective and less expen-
sive medicines for preventing preterm birth and treating 
sepsis, point of care diagnostics for infections, maternal 
vaccines to prevent newborn infections, and basic science 
work on causal pathways for identifying intervention tar-
gets and biomarkers for preterm birth, IUGR, and antepar-
tum stillbirths. It is noteworthy that preterm prevention 
was not ranked highly, even though it may have the largest 
impact. This appears to be the result of these questions be-
ing scored low in answerability.
The relatively lower scores for the “development” and “dis-
covery” groups of research questions may have several pos-
sible explanations. First, more than 95% of the neonatal 
deaths occur in low and middle–income countries (LMICs). 
Therefore, research addressing neonatal health issues that 
are relatively more important in wealthy countries may be 
Table 3. Top ten discovery research priorities in discovery for improving newborn health and birth outcomes by 2025 as ranked by 
91 experts
Rank ReseaRch questions total scoRe 
(confiDence 
inteRval)
agReement 
between 
scoReRs
55 Can stable surfactant with simpler novel modes of administration increase the use and availability of surfactant for 
preterm babies at risk of respiratory distress syndrome?
71 (62–73) 49
71 Can the method to diagnose fetal distress in labour be more accurate and affordable? 66 (57–71) 49
97 Can strategies for prevention and treatment of intrauterine growth restriction be developed? 64 (51–68) 46
105 Can novel tocolytic agents to delay or stop preterm labour be developed in order to reduce neonatal mortality and 
morbidity?
63 (54–68) 42
116 Can major causal pathways and risk factors for antepartum stillbirth be identified? 61 (52–66) 43
118 Can novel point of care diagnostics for congenital syphilis be identified in low resource setting to improve manage-
ment?
60 (53–64) 49
120 Can novel antibiotic or other biological agents be identified? 60 (51–65) 40
121 Can the new method identify intrauterine growth restriction at the early stage (including biomarkers) and predict 
abnormal postnatal growth and body composition?
60 (52–63) 43
125 Can novel vaccines for maternal immunization be developed and evaluated to prevent newborn infections (eg, GBS, 
Klebsiella, E coli, Staph)?
60 (51–64) 41
129 Can preterm birth be delayed or averted with antioxidant and/or nutrient supplementation (eg, Vitamin D, ome-
ga–3 fatty acids)?
58 (48–63) 42
GBS – group B streptococcus, Staph – staphylococcus
Table 4. Overall scoring pattern by profile of experts
meDian (iqR)
all scoReRs 
(n = 91)
ReseaRcheRs 
(n = 61)
pRogRamme 
expeRts (n = 30)
TOTAL SCORE
Delivery 82 (80–86) 83 (78–86) 86 (81–87)
Development 74 (72–74) 75 (71–76) 75 (68–79)
Discovery 61 (59–64) 62 (60–62) 63 (58–65)
AGREEMENT
Delivery 67 (65–72) 68 (64–73) 70 (65–75)
Development 57 (55–58) 58 (56–60) 55 (54–62)
Discovery 43 (42–49) 45 (42–47) 44 (39–49)
ANSWERABLE?
Delivery 92 (87–94) 92 (88–95) 91 (90–94)
Development 84 (82–89) 87 (81–90) 84 (78–89)
Discovery 76 (73–78) 76 (74–79) 76 (70–79)
EFFICACY?
Delivery 87 (84–91) 87 (83–91) 88 (84–90)
Development 81 (77–83) 84 (79–84) 78 (76–81)
Discovery 68 (64–70) 68 (65–72) 69 (59–72)
DELIVERABILITY?
Delivery 85 (82–89) 86 (82–91) 87 (82–89)
Development 77 (75–80) 79 (77–81) 74 (70–84)
Discovery 68 (66–72) 69 (64–72) 70 (64–72)
IMPACT?
Delivery 68 (62–72) 65 (58–70) 73 (69–80)
Development 56 (53–57) 53 (52–58) 62 (52–65)
Discovery 46 (39–50) 46 (38–48) 44 (36–54)
EQUITY?
Delivery 84 (81–88) 84 (76–89) 87 (79–88)
Development 74 (66–77) 71 (65–76) 76 (75–80)
Discovery 54 (50–59) 52 (50–58) 53 (50–65)
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perceived to contribute less to global reduction in mortality 
and morbidity, explaining some of the lower scores received 
by potentially promising research on novel interventions 
based on high technologies. Second, “discovery” research 
often takes longer to be translated into measurable benefits 
in terms of mortality burden reduction, and by definition 
the link to reduction in mortality and inequity is less direct. 
One specific example is research on prevention of preterm 
birth – while it was likely to have high impact, it was ranked 
only 129th among the 205 questions. Thereby, respondents 
sent a message that this research question would likely be 
difficult to answer given the current stage of knowledge. 
Third, the process of delivery of novel interventions usu-
ally requires specific funding mechanisms, such as PEPFAR 
or Advance Market Commitment (AMC), which require 
time for a political agreement [34,35].
The CHNRI process we followed for setting priorities has 
several strengths. The methodology is transparent, replica-
ble, and feasible to apply via e–mail [8–12, 27–33]. The out-
put is intuitive and easily understood, and it has been refined 
and improved through many exercises over the past several 
years [36]. In this particular exercise, further improvements 
have been introduced to the process. We chose a large num-
ber of experts based on their productivity in the previous five 
years using Web of Science®, thus transparently identifying 
the group that was most likely to understand the field and 
its present research challenges and gaps. A very wide global 
network of programme experts in the Saving Newborn Lives’ 
Network was also invited. Moreover, we used online data 
collection tools, such as Survey Monkey® and Google Ana-
lytics®, which allowed monitoring of the progress of the ex-
ercise in real time, ensured adequate representation of ex-
perts by their background and region, and increased the 
efficiency of data management. Finally, 132 experts proposed 
research questions and 91 scored all the questions in this 
exercise; this is considerably more than in previous priority 
setting exercises using CHNRI methodology, where we typ-
ically involved fewer scorers, research ideas, and criteria 
scored by each expert.
There may be concern that the results derived from the 
CHNRI approach might represent only the collective opin-
ion of the limited group of people who were included in the 
process. However, we were able to obtain questions and 
scores from a large number of experts worldwide, who were 
selected in a transparent and replicable manner, based on 
their research productivity in the field. The large number of 
participants and the protection against potential bias pro-
vided by the CHNRI approach make our results more cred-
ible, although it remains apparent that the highest scored 
questions may still be biased towards those that researchers 
are most familiar with and so may bias reflect research al-
ready in progress. This issue may be particularly relevant in 
view that only about a quarter of originally invited research-
ers, policy makers and programme experts eventually con-
tributed to generating research questions, and only about 
one in six completed the scoring process, making response 
bias an important potential concern. Second, even though 
the list of proposed questions was reviewed and refined be-
fore sending for scoring, there were still overlaps in some 
research questions, possibly creating confusion in scoring 
such questions. Those and other possible strengths and lim-
itations of CHNRI methodology are described and discussed 
in greater detail in Online Supplementary Document.
A recent analysis of funding committed globally to improv-
ing neonatal health and birth outcomes has shown that do-
nor mention of the “newborn” has increased quite sharply 
since 2005. However, given a total of only 10% of all do-
nor aid to RMNCH mentioning the word “newborn”, and 
only 0.01% referring to interventions expected to reduce 
newborn deaths, it still seems unlikely that donor aid is 
commensurate with the large burden of 3.0 million new-
born deaths each year, or with the burden of morbidity, 
developmental and long–term health outcomes [37]. The 
word “stillbirth” occurred only twice in the OECD database 
between 2002 and 2010, suggesting even lower attention 
for the world’s 2.7 million stillbirths.
Large inequities in current research funding support exist 
not only in the amounts invested in newborn health in 
comparison to other diseases globally, but also between dif-
ferent neonatal conditions themselves. Conditions that af-
fect newborns in high–income countries receive more 
funding and attention than conditions that largely affect 
newborns in low–income countries. For instance, the re-
search on care of preterm babies in neonatal intensive care 
units has received considerably more funding over the past 
several years in comparison to intrapartum–related birth 
outcomes or newborn sepsis [38].
The results presented in this paper will assist both the do-
nors and the researchers in setting evidence based priori-
ties to address the key gaps in knowledge, that could make 
the most difference in saving newborn lives and preventing 
stillbirth. In addition, attention to many of these questions 
could also improve maternal and child health outcomes. 
Likewise, research priorities to address other related areas 
such as maternal, child and adolescent health and health 
system issues may have substantial effect on newborn 
health. Complementary exercises are under way to iden-
tify research priorities in these areas. Using the identified 
research priorities, WHO, SNL and other partners, that are 
linked to the Every Newborn action plan launched in 2014 
[39], will work to generate research interests among key 
national stakeholders, governments, NGOs, and research 
institutes, while encouraging research funders to support 
these priorities. We will track research funding, relevant 
request for proposals and trial registers to monitor if the 
priorities identified by this exercise are being addressed, 
and highlight those that are not being addressed.
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